The expression of soluble CD163 was only slightly elevated in SIRS patients compared to control group (S3B Fig) and also normalization to the admission day did not yield significant differences but an increasing trend is visible (S3D Fig). The gene discussed is CD163; the disease is systemic inflammatory response syndrome.